112 related articles for article (PubMed ID: 9620304)
21. Mild recessive epidermolytic hyperkeratosis associated with a novel keratin 10 donor splice-site mutation in a family of Norfolk terrier dogs.
Credille KM; Barnhart KF; Minor JS; Dunstan RW
Br J Dermatol; 2005 Jul; 153(1):51-8. PubMed ID: 16029326
[TBL] [Abstract][Full Text] [Related]
22. The keratins and their disorders.
Rugg EL; Leigh IM
Am J Med Genet C Semin Med Genet; 2004 Nov; 131C(1):4-11. PubMed ID: 15452838
[TBL] [Abstract][Full Text] [Related]
23. The use of retinoic acid to probe the relation between hyperproliferation-associated keratins and cell proliferation in normal and malignant epidermal cells.
Kopan R; Fuchs E
J Cell Biol; 1989 Jul; 109(1):295-307. PubMed ID: 2473080
[TBL] [Abstract][Full Text] [Related]
24. Bullous congenital ichthyosiform erythroderma of Brocq.
Kucharekova M; Mosterd K; Winnepenninckx V; van Geel M; Sommer A; van Steensel MA
Int J Dermatol; 2007 Nov; 46 Suppl 3():36-8. PubMed ID: 17973888
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of cross-reacting anti-human antibodies in the euthymic hairless guinea pig model (HGP) suggests that the HGP may be a model for the study of proliferative skin disease.
Smith KJ; Graham JS; Skelton HG; O'Leary T; Moeller RB; Okerberg CV; Hurst CG
J Dermatol Sci; 1997 Mar; 14(3):240-50. PubMed ID: 9138482
[TBL] [Abstract][Full Text] [Related]
26. [Mutation analysis of KRT10 gene in a patient with bullous congenital ichthyosiform erythroderma].
Zhang SD; Liu JJ; Tian W; Zhao ZJ; Zhao JJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Aug; 28(4):421-3. PubMed ID: 21811984
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions.
Blessing M; Schirmacher P; Kaiser S
J Cell Biol; 1996 Oct; 135(1):227-39. PubMed ID: 8858176
[TBL] [Abstract][Full Text] [Related]
28. Mutations in the genes for epidermal keratins in epidermolysis bullosa and epidermolytic hyperkeratosis.
Leigh IM; Lane EB
Arch Dermatol; 1993 Dec; 129(12):1571-7. PubMed ID: 7504434
[TBL] [Abstract][Full Text] [Related]
29. Hyperproliferation markers in ear canal epidermis.
Caliman e Gurgel JD; Pereira SB; Alves AL; Ribeiro FQ
Braz J Otorhinolaryngol; 2010; 76(5):667-71. PubMed ID: 20963355
[TBL] [Abstract][Full Text] [Related]
30. Identification of markers for nipple epidermis: changes in expression during pregnancy and lactation.
Eastwood J; Offutt C; Menon K; Keel M; Hrncirova P; Novotny MV; Arnold R; Foley J
Differentiation; 2007 Jan; 75(1):75-83. PubMed ID: 17244023
[TBL] [Abstract][Full Text] [Related]
31. Unusual patterns of keratin expression in the overlying epidermis of patients with dermatofibromas: biochemical alterations in the epidermis as a consequence of dermal tumors.
Stoler A; Duvic M; Fuchs E
J Invest Dermatol; 1989 Dec; 93(6):728-38. PubMed ID: 2479695
[TBL] [Abstract][Full Text] [Related]
32. Diseases of epidermal keratins and their linker proteins.
Uitto J; Richard G; McGrath JA
Exp Cell Res; 2007 Jun; 313(10):1995-2009. PubMed ID: 17531221
[TBL] [Abstract][Full Text] [Related]
33. Keratins and skin disorders.
Rao KS; Babu KK; Gupta PD
Cell Biol Int; 1996 Apr; 20(4):261-74. PubMed ID: 8664850
[TBL] [Abstract][Full Text] [Related]
34. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
35. Inducible mouse models for inherited skin diseases: implications for skin gene therapy.
Arin MJ; Roop DR
Cells Tissues Organs; 2004; 177(3):160-8. PubMed ID: 15388990
[TBL] [Abstract][Full Text] [Related]
36. [Inherited abnormalities of the epidermis caused by mutation of keratins].
Hohl D
Ann Dermatol Venereol; 1995; 122(4):162-6. PubMed ID: 8526410
[TBL] [Abstract][Full Text] [Related]
37. A mouse keratin 1 mutation causes dark skin and epidermolytic hyperkeratosis.
McGowan KA; Aradhya S; Fuchs H; de Angelis MH; Barsh GS
J Invest Dermatol; 2006 May; 126(5):1013-6. PubMed ID: 16528356
[TBL] [Abstract][Full Text] [Related]
38. Long-term alteration in the expression of keratins 6 and 16 in the epidermis of mice after chronic UVB exposure.
Sano T; Kume T; Fujimura T; Kawada H; Higuchi K; Iwamura M; Hotta M; Kitahara T; Takema Y
Arch Dermatol Res; 2009 Mar; 301(3):227-37. PubMed ID: 18979106
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanism of kallikrein-related peptidase 8/neuropsin-induced hyperkeratosis in inflamed skin.
Shingaki K; Matsuzaki S; Taniguchi M; Kubo T; Fujiwara T; Kanazawa S; Yamamoto A; Tamura H; Maeda T; Ooi K; Matsumoto K; Shiosaka S; Tohyama M
Br J Dermatol; 2010 Sep; 163(3):466-75. PubMed ID: 20500798
[TBL] [Abstract][Full Text] [Related]
40. Development and progression of alopecia in the vitamin D receptor null mouse.
Bikle DD; Elalieh H; Chang S; Xie Z; Sundberg JP
J Cell Physiol; 2006 May; 207(2):340-53. PubMed ID: 16419036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
